P2rx7 genetic deletion in PS19 tauopathy mice

Validation Score: 0.900 Price: $0.50 Alzheimer's disease/tauopathy PS19 tauopathy mice Status: proposed

What This Experiment Tests

Validation experiment designed to validate causal mechanisms targeting P2rx7 in PS19 tauopathy mice. Primary outcome: Brain atrophy, tau accumulation, and cognitive impairment

Description

This experiment examined the effects of genetic deletion of P2rx7 in PS19 tauopathy mice, a mouse model of Alzheimer's disease. Researchers compared PS19 mice with intact P2rx7 to those with genetic deletion of P2rx7, measuring brain atrophy, tau accumulation, and cognitive function. The study aimed to determine whether P2rx7 deletion could mitigate the pathological features of tauopathy. Behavioral assessments were likely conducted to evaluate cognitive impairment, while histological and biochemical analyses were performed to assess brain atrophy and tau protein accumulation in various brain regions.

TARGET GENE

P2rx7

MODEL SYSTEM

PS19 tauopathy mice

ESTIMATED COST

TIMELINE

0 months

PATHWAY

P2RX7-mediated ATP signaling and neuroinflammation

SOURCE

extracted_from_pmid_40678243

PRIMARY OUTCOME

Brain atrophy, tau accumulation, and cognitive impairment

Scoring Dimensions

📖 Wiki Pages

P2RX7 Proteinprotein P2RX7 Genegene Alzheimer's Diseasedisease TH Genegene Tauopathymechanism Brain Regionsindex Alzheimer's Diseasedisease Researchersindex Tau Proteinprotein neuroinflammationmechanism

Protocol

Establish PS19 tauopathy mice cohorts for Alzheimer's disease/tauopathy and predefine inclusion, exclusion, and quality-control criteria before intervention. 2. Apply the experimental manipulation described for P2rx7, alongside matched control or comparator arms, and document dose, exposure window, and sample timing in a locked protocol log. 3. Measure Brain atrophy, tau accumulation, and cognitive impairment together with orthogonal secondary readouts such as molecular, imaging, behavioral, or safety endpoints that are appropriate to the title and study design. 4. Use blinded outcome assessment where feasible, prespecified statistical analysis, and replicate the core readout across biological replicates or an independent validation subset. 5.

...

Expected Outcomes

The intervention targeting P2rx7 shifts Brain atrophy, tau accumulation, and cognitive impairment in the predicted direction relative to the matched control arm.

Secondary disease-relevant readouts in Alzheimer's disease/tauopathy remain directionally concordant with the primary endpoint rather than showing isolated single-assay effects.

The effect persists after adjustment for baseline covariates, batch effects, or repeated-measures structure used in the study design.

Success Criteria

Prespecified primary endpoint (Brain atrophy, tau accumulation, and cognitive impairment) improves versus control with p < 0.05 or an equivalent corrected threshold used by the study.
The effect size is biologically meaningful and reproduced across technical/biological replicates or the validation subset.
Safety, data quality, and missingness remain within protocol-defined bounds so the result is interpretable rather than driven by attrition or assay failure.

Related Hypotheses (1)

P2RX7-Mediated Exosome Secretion Blockade0.552

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.